A carregar...

Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials

Antipsychotic-induced dyslipidemia could increase the risk of cardiovascular diseases. This is a meta-analysis of randomized double-blind placebo-controlled trials to examine the efficacy and safety of adjunctive metformin for dyslipidemia induced by antipsychotics in schizophrenia. The standardized...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Psychiatry
Main Authors: Jiang, Wen-Long, Cai, Dong-Bin, Yin, Fei, Zhang, Ling, Zhao, Xi-Wu, He, Jie, Ng, Chee H., Ungvari, Gabor S., Sim, Kang, Hu, Mei-Ling, Zheng, Wei, Xiang, Yu-Tao
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7181777/
https://ncbi.nlm.nih.gov/pubmed/32327628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-020-0785-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!